Stryker Corp
XMUN:SYK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Stryker Corp
XMUN:SYK
|
US |
|
U
|
Under Armour Inc
NYSE:UA
|
US |
|
Q
|
Qualcomm Inc
F:QCI
|
US |
|
SGS SA
SIX:SGSN
|
CH |
|
MercadoLibre Inc
BMV:MELIN
|
UY |
Stryker Corp
Stryker makes medical devices and hospital equipment that help doctors treat injuries, replace damaged joints, and perform surgery. Its products include hip and knee implants, surgical tools, operating-room systems, trauma devices, and equipment used in emergency rooms and ambulances. It also sells products for neurovascular care, which are used in treating certain stroke and brain conditions. The company sells mainly to hospitals, surgery centers, and other healthcare providers. It earns money by selling devices and equipment upfront and, in some cases, by selling related consumables and replacement parts that are used during procedures. Its customers buy Stryker products because they sit in the middle of the care process: they help surgeons do the operation, help clinicians move patients, and support recovery after treatment. What makes Stryker's business model different is that it sits inside the medical workflow rather than at the patient-facing end of care. Many of its products are used every day in high-stakes settings, which makes performance, reliability, and training important. That gives Stryker a strong role in hospitals as a supplier of specialized tools that are hard to replace quickly.
Stryker makes medical devices and hospital equipment that help doctors treat injuries, replace damaged joints, and perform surgery. Its products include hip and knee implants, surgical tools, operating-room systems, trauma devices, and equipment used in emergency rooms and ambulances. It also sells products for neurovascular care, which are used in treating certain stroke and brain conditions.
The company sells mainly to hospitals, surgery centers, and other healthcare providers. It earns money by selling devices and equipment upfront and, in some cases, by selling related consumables and replacement parts that are used during procedures. Its customers buy Stryker products because they sit in the middle of the care process: they help surgeons do the operation, help clinicians move patients, and support recovery after treatment.
What makes Stryker's business model different is that it sits inside the medical workflow rather than at the patient-facing end of care. Many of its products are used every day in high-stakes settings, which makes performance, reliability, and training important. That gives Stryker a strong role in hospitals as a supplier of specialized tools that are hard to replace quickly.
Cyber hit: Stryker said the late-quarter cyber incident distorted Q1 results, but the company was fully operational again by the week of April 1 and expects most lost sales to come back over the rest of the year.
Guidance held: Management reiterated full-year 2026 organic sales growth of 8% to 9.5% and adjusted EPS of $14.90 to $15.10, saying the business remains in healthy end markets with strong procedural demand.
Q1 pressure: Organic sales grew 2.4%, while adjusted EPS fell to $2.60, hurt by lost manufacturing absorption, tariffs, and higher interest expense.
Margins: Adjusted gross margin was 63.6% and adjusted operating margin was 21.1%; management said full-year margin expectations are unchanged despite some first-half pressure from tariffs and the cyber disruption.
Pipeline/M&A: Stryker announced AVS, expects to close it in Q2, and said it remains active in M&A, especially in peripheral vascular and other adjacent spaces.
Robotics strength: Mako installations had their best ever Q1, utilization remained high, and the company expects continued momentum from Mako 4, Mako Shoulder, and other launches to support orthopedic outgrowth.
Customer tone: Management said hospital demand stayed healthy, capital orders remained elevated, and customer feedback during the recovery was very positive.
Management
Kevin A. Lobo is a prominent business executive known for his role as Chairman and CEO of Stryker Corporation, a leading global medical technology company. He joined Stryker in 2011 as Group President of Orthopaedics, and shortly after, in October 2012, he was appointed President and CEO. Under his leadership, Stryker has expanded its global reach and product offerings, maintaining a strong presence in the medical technology industry. Lobo has been instrumental in guiding the company's strategic acquisitions and innovations, focusing on diversifying its product portfolio and enhancing operational efficiencies. Before joining Stryker, Lobo held senior leadership roles at Johnson & Johnson, where he gained extensive experience in finance, operations, and management. He has a background in finance and accounting, holding a bachelor's degree in Commerce from McGill University and an MBA from the University of Toronto. His leadership style is characterized by a strong commitment to strategic growth, sustainability, and ethical business practices.
Lobo has been instrumental in guiding the company's strategic acquisitions and innovations, focusing on diversifying its product portfolio and enhancing operational efficiencies. Before joining Stryker, Lobo held senior leadership roles at Johnson & Johnson, where he gained extensive experience in finance, operations, and management. He has a background in finance and accounting, holding a bachelor's degree in Commerce from McGill University and an MBA from the University of Toronto. His leadership style is characterized by a strong commitment to strategic growth, sustainability, and ethical business practices.
Glenn S. Boehnlein is the Vice President, Chief Financial Officer (CFO), and Secretary of Stryker Corporation, a leading global medical technology company. He has been with Stryker since 2003, initially joining as the Vice President of Finance and Corporate Controller. In 2016, he was appointed CFO, where he oversees the company's financial operations, including accounting, budgeting, and financial planning. Boehnlein holds a Bachelor of Business Administration in Accounting from the University of Notre Dame and a Master of Business Administration from the University of Chicago Booth School of Business. His leadership in financial strategy has been pivotal in Stryker's growth and success in the medical technology industry.
Viju S. Menon is a well-known executive associated with Stryker Corporation, a leading medical technologies firm. As a prominent leader within the company, he has held significant roles that have contributed to the company's growth and innovation. Menon joined Stryker bringing with him a wealth of experience from various industries. His expertise spans operations management, process optimization, and strategic development. At Stryker, he has been instrumental in enhancing the company’s operational efficiencies, supply chain management, and overall business strategies. His leadership style is often characterized by a strong focus on fostering innovation, improving customer satisfaction, and driving sustainable growth. Menon's contributions have been vital in maintaining Stryker's position as a leader in the medical technology sector.
J. Andrew Pierce is a notable figure associated with Stryker Corporation, a leading medical technology company. As of the latest information available, he serves as the Group President of MedSurg and Neurotechnology at Stryker. In this capacity, he oversees Stryker's operations related to its MedSurg and Neurotechnology business segments, focusing on driving innovation and growth within these areas. Pierce joined Stryker in 1990 and has held various leadership roles throughout his career, demonstrating strong expertise and a significant impact on the company's development. His leadership skills and strategic vision have been instrumental in expanding Stryker's market presence and enhancing its product offerings. Under his guidance, the MedSurg and Neurotechnology divisions have achieved substantial progress, contributing to Stryker's overall success as a prominent player in the medical technology industry. Pierce’s commitment to innovation, quality, and customer satisfaction underscores his effectiveness as a leader at Stryker.
Pierce joined Stryker in 1990 and has held various leadership roles throughout his career, demonstrating strong expertise and a significant impact on the company's development. His leadership skills and strategic vision have been instrumental in expanding Stryker's market presence and enhancing its product offerings.
Under his guidance, the MedSurg and Neurotechnology divisions have achieved substantial progress, contributing to Stryker's overall success as a prominent player in the medical technology industry. Pierce’s commitment to innovation, quality, and customer satisfaction underscores his effectiveness as a leader at Stryker.
Spencer S. Stiles is an executive at Stryker Corp., a leading medical technologies firm. He has held various leadership roles within the company. Currently, he serves as the Group President of Orthopaedics and Spine, overseeing the strategic direction and operation of these divisions. Stiles joined Stryker in 1996 and has held numerous positions, gaining extensive experience across different business units. His leadership has been instrumental in driving growth and innovation within the organization. Stiles is known for his strong focus on operational excellence and delivering value to both the company and its customers.
William E. Berry Jr. is a well-regarded business executive who served as the Vice President, Corporate Secretary, and Chief Legal Officer of Stryker Corporation. In his role at Stryker, a leading medical technologies firm, Berry was responsible for overseeing the legal affairs of the company, including corporate governance and compliance matters. His expertise in legal management and dedication to ensuring ethical practices were key in maintaining Stryker’s reputable standing in the healthcare sector. Berry's extensive legal background, combined with his experience in corporate governance, positioned him as a valuable leader within the company. His work contributed significantly to navigating the complex regulatory environment of the medical device industry. Berry's leadership and strategic insight were instrumental in steering the company's growth and success in deploying advanced medical technologies worldwide.
Berry's extensive legal background, combined with his experience in corporate governance, positioned him as a valuable leader within the company. His work contributed significantly to navigating the complex regulatory environment of the medical device industry. Berry's leadership and strategic insight were instrumental in steering the company's growth and success in deploying advanced medical technologies worldwide.
Robert C. Cohen is a prominent executive known for his leadership at Stryker Corporation, a global leader in medical technology. At Stryker, he has held significant roles, especially within the company's Orthopaedics division. As President of Stryker's Digital, Robotics, and Enabling Technologies group, Cohen played a key role in advancing the company's innovative solutions, focusing on robotics and digital advancements that align with the future of orthopedic surgeries. Under his leadership, Stryker has seen developments in robotic-assisted surgery with their Mako system, as well as other digital technology mergers that have bolstered the company's presence in the medical tech industry. Robert Cohen is recognized for his capacity to drive growth, his strategic vision, and his commitment to improving patient outcomes through cutting-edge technology. His deep industry experience and forward-thinking approach continue to propel Stryker's mission of making healthcare better.
Under his leadership, Stryker has seen developments in robotic-assisted surgery with their Mako system, as well as other digital technology mergers that have bolstered the company's presence in the medical tech industry. Robert Cohen is recognized for his capacity to drive growth, his strategic vision, and his commitment to improving patient outcomes through cutting-edge technology. His deep industry experience and forward-thinking approach continue to propel Stryker's mission of making healthcare better.
As of the last available information, Alan Douville served as an executive at Stryker Corporation. Stryker is a well-known medical technologies firm, and executives play crucial roles in overseeing its operations and strategic direction. Their leadership is essential in shaping the company's innovations in medical devices and equipment, which contributes to advancements in healthcare. However, specific details about Alan Douville’s role, accomplishments, or biography at Stryker Corp are not readily available publicly. Therefore, detailed personal or career-related information about him might be limited to internal company resources or private documents. If you are seeking specific details, it would be beneficial to consult Stryker's official resources or press releases.
Jason Beach is not widely recognized in public directories or notable executive profiles associated with Stryker Corporation, a prominent medical technology company. Without specific information or verified sources, it is challenging to provide a detailed biography for an executive by that name from Stryker Corp. If you have more context or specific details about his role or contributions, it might help refine the search. Otherwise, based on the available data, I would conclude "FALSE" regarding any widely acknowledged biography of Jason Beach at Stryker Corporation.
Robert S. Fletcher is an executive known for his leadership role at Stryker Corporation, a leading medical technologies firm. At Stryker, Fletcher has been instrumental in driving the company's strategic initiatives, focusing on innovation and growth across its diverse product lines. Under his leadership, Stryker has advanced in areas such as orthopedics, medical and surgical equipment, and neurotechnology. Fletcher has a strong background in the healthcare and medical devices industry, bringing with him a wealth of experience that supports the company's mission to make health care better. He is recognized for his ability to align Stryker's operations with global health care demands, ensuring the organization remains at the forefront of technological advancement and patient care enhancement. His tenure at Stryker is marked by a commitment to quality and a forward-thinking approach to addressing the needs of health care professionals and patients worldwide. Through fostering innovation, improving operational efficiencies, and managing a dynamic portfolio, Fletcher continues to contribute significantly to Stryker’s prominence in the global market.
Fletcher has a strong background in the healthcare and medical devices industry, bringing with him a wealth of experience that supports the company's mission to make health care better. He is recognized for his ability to align Stryker's operations with global health care demands, ensuring the organization remains at the forefront of technological advancement and patient care enhancement.
His tenure at Stryker is marked by a commitment to quality and a forward-thinking approach to addressing the needs of health care professionals and patients worldwide. Through fostering innovation, improving operational efficiencies, and managing a dynamic portfolio, Fletcher continues to contribute significantly to Stryker’s prominence in the global market.
